 | • レポートコード：QFJ1-4981 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、口唇ヘルペス治療＆予防の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（バラシクロビル、アシクロビル、ファムシクロビル、ドコサノール、その他）、用途別市場規模（外用、経口、注射）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・口唇ヘルペス治療＆予防の市場動向 ・企業の競争状況、市場シェア ・口唇ヘルペス治療＆予防の種類別市場規模と予測2016-2027（バラシクロビル、アシクロビル、ファムシクロビル、ドコサノール、その他） ・口唇ヘルペス治療＆予防の用途別市場規模と予測2016-2027（外用、経口、注射） ・口唇ヘルペス治療＆予防の北米市場規模2016-2027（アメリカ、カナダ） ・口唇ヘルペス治療＆予防の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・口唇ヘルペス治療＆予防のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・口唇ヘルペス治療＆予防の中南米市場規模2016-2027（メキシコ、ブラジル） ・口唇ヘルペス治療＆予防の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（GSK、Novartis、Teva、Mylan、Cadila、Apotex、Daewoong Pharmaceutical、Livzon、Luoxin、Med shine、Bayer(Campho Phenique)、Blistex、Kelun Group、Hikma、Haiwang、Carmex、Cipher） ・結論 |
Market Analysis and Insights: Global Treatment and Prevention of Herpes Labialis Market
The global Treatment and Prevention of Herpes Labialis market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Treatment and Prevention of Herpes Labialis market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Treatment and Prevention of Herpes Labialis market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Treatment and Prevention of Herpes Labialis market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Treatment and Prevention of Herpes Labialis market.
Global Treatment and Prevention of Herpes Labialis Scope and Market Size
Treatment and Prevention of Herpes Labialis market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Treatment and Prevention of Herpes Labialis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Valacyclovir
Aciclovir
Famciclovir
Docosanol
Other
Segment by Application
External Use
Oral
Injection
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
GSK
Novartis
Teva
Mylan
Cadila
Apotex
Daewoong Pharmaceutical
Livzon
Luoxin
Med shine
Bayer(Campho Phenique)
Blistex
Kelun Group
Hikma
Haiwang
Carmex
Cipher
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Treatment and Prevention of Herpes Labialis Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Valacyclovir
1.2.3 Aciclovir
1.2.4 Famciclovir
1.2.5 Docosanol
1.2.6 Other
1.3 Market by Application
1.3.1 Global Treatment and Prevention of Herpes Labialis Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 External Use
1.3.3 Oral
1.3.4 Injection
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Treatment and Prevention of Herpes Labialis Market Perspective (2016-2027)
2.2 Treatment and Prevention of Herpes Labialis Growth Trends by Regions
2.2.1 Treatment and Prevention of Herpes Labialis Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Treatment and Prevention of Herpes Labialis Historic Market Share by Regions (2016-2021)
2.2.3 Treatment and Prevention of Herpes Labialis Forecasted Market Size by Regions (2022-2027)
2.3 Treatment and Prevention of Herpes Labialis Industry Dynamic
2.3.1 Treatment and Prevention of Herpes Labialis Market Trends
2.3.2 Treatment and Prevention of Herpes Labialis Market Drivers
2.3.3 Treatment and Prevention of Herpes Labialis Market Challenges
2.3.4 Treatment and Prevention of Herpes Labialis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Treatment and Prevention of Herpes Labialis Players by Revenue
3.1.1 Global Top Treatment and Prevention of Herpes Labialis Players by Revenue (2016-2021)
3.1.2 Global Treatment and Prevention of Herpes Labialis Revenue Market Share by Players (2016-2021)
3.2 Global Treatment and Prevention of Herpes Labialis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Treatment and Prevention of Herpes Labialis Revenue
3.4 Global Treatment and Prevention of Herpes Labialis Market Concentration Ratio
3.4.1 Global Treatment and Prevention of Herpes Labialis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Treatment and Prevention of Herpes Labialis Revenue in 2020
3.5 Treatment and Prevention of Herpes Labialis Key Players Head office and Area Served
3.6 Key Players Treatment and Prevention of Herpes Labialis Product Solution and Service
3.7 Date of Enter into Treatment and Prevention of Herpes Labialis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Treatment and Prevention of Herpes Labialis Breakdown Data by Type
4.1 Global Treatment and Prevention of Herpes Labialis Historic Market Size by Type (2016-2021)
4.2 Global Treatment and Prevention of Herpes Labialis Forecasted Market Size by Type (2022-2027)
5 Treatment and Prevention of Herpes Labialis Breakdown Data by Application
5.1 Global Treatment and Prevention of Herpes Labialis Historic Market Size by Application (2016-2021)
5.2 Global Treatment and Prevention of Herpes Labialis Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Treatment and Prevention of Herpes Labialis Market Size (2016-2027)
6.2 North America Treatment and Prevention of Herpes Labialis Market Size by Type
6.2.1 North America Treatment and Prevention of Herpes Labialis Market Size by Type (2016-2021)
6.2.2 North America Treatment and Prevention of Herpes Labialis Market Size by Type (2022-2027)
6.2.3 North America Treatment and Prevention of Herpes Labialis Market Size by Type (2016-2027)
6.3 North America Treatment and Prevention of Herpes Labialis Market Size by Application
6.3.1 North America Treatment and Prevention of Herpes Labialis Market Size by Application (2016-2021)
6.3.2 North America Treatment and Prevention of Herpes Labialis Market Size by Application (2022-2027)
6.3.3 North America Treatment and Prevention of Herpes Labialis Market Size by Application (2016-2027)
6.4 North America Treatment and Prevention of Herpes Labialis Market Size by Country
6.4.1 North America Treatment and Prevention of Herpes Labialis Market Size by Country (2016-2021)
6.4.2 North America Treatment and Prevention of Herpes Labialis Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Treatment and Prevention of Herpes Labialis Market Size (2016-2027)
7.2 Europe Treatment and Prevention of Herpes Labialis Market Size by Type
7.2.1 Europe Treatment and Prevention of Herpes Labialis Market Size by Type (2016-2021)
7.2.2 Europe Treatment and Prevention of Herpes Labialis Market Size by Type (2022-2027)
7.2.3 Europe Treatment and Prevention of Herpes Labialis Market Size by Type (2016-2027)
7.3 Europe Treatment and Prevention of Herpes Labialis Market Size by Application
7.3.1 Europe Treatment and Prevention of Herpes Labialis Market Size by Application (2016-2021)
7.3.2 Europe Treatment and Prevention of Herpes Labialis Market Size by Application (2022-2027)
7.3.3 Europe Treatment and Prevention of Herpes Labialis Market Size by Application (2016-2027)
7.4 Europe Treatment and Prevention of Herpes Labialis Market Size by Country
7.4.1 Europe Treatment and Prevention of Herpes Labialis Market Size by Country (2016-2021)
7.4.2 Europe Treatment and Prevention of Herpes Labialis Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Treatment and Prevention of Herpes Labialis Market Size (2016-2027)
8.2 Asia-Pacific Treatment and Prevention of Herpes Labialis Market Size by Type
8.2.1 Asia-Pacific Treatment and Prevention of Herpes Labialis Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Treatment and Prevention of Herpes Labialis Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Treatment and Prevention of Herpes Labialis Market Size by Type (2016-2027)
8.3 Asia-Pacific Treatment and Prevention of Herpes Labialis Market Size by Application
8.3.1 Asia-Pacific Treatment and Prevention of Herpes Labialis Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Treatment and Prevention of Herpes Labialis Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Treatment and Prevention of Herpes Labialis Market Size by Application (2016-2027)
8.4 Asia-Pacific Treatment and Prevention of Herpes Labialis Market Size by Region
8.4.1 Asia-Pacific Treatment and Prevention of Herpes Labialis Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Treatment and Prevention of Herpes Labialis Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Treatment and Prevention of Herpes Labialis Market Size (2016-2027)
9.2 Latin America Treatment and Prevention of Herpes Labialis Market Size by Type
9.2.1 Latin America Treatment and Prevention of Herpes Labialis Market Size by Type (2016-2021)
9.2.2 Latin America Treatment and Prevention of Herpes Labialis Market Size by Type (2022-2027)
9.2.3 Latin America Treatment and Prevention of Herpes Labialis Market Size by Type (2016-2027)
9.3 Latin America Treatment and Prevention of Herpes Labialis Market Size by Application
9.3.1 Latin America Treatment and Prevention of Herpes Labialis Market Size by Application (2016-2021)
9.3.2 Latin America Treatment and Prevention of Herpes Labialis Market Size by Application (2022-2027)
9.3.3 Latin America Treatment and Prevention of Herpes Labialis Market Size by Application (2016-2027)
9.4 Latin America Treatment and Prevention of Herpes Labialis Market Size by Country
9.4.1 Latin America Treatment and Prevention of Herpes Labialis Market Size by Country (2016-2021)
9.4.2 Latin America Treatment and Prevention of Herpes Labialis Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size (2016-2027)
10.2 Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size by Type
10.2.1 Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size by Type (2016-2027)
10.3 Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size by Application
10.3.1 Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size by Application (2016-2027)
10.4 Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size by Country
10.4.1 Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK Treatment and Prevention of Herpes Labialis Introduction
11.1.4 GSK Revenue in Treatment and Prevention of Herpes Labialis Business (2016-2021)
11.1.5 GSK Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Treatment and Prevention of Herpes Labialis Introduction
11.2.4 Novartis Revenue in Treatment and Prevention of Herpes Labialis Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Teva
11.3.1 Teva Company Details
11.3.2 Teva Business Overview
11.3.3 Teva Treatment and Prevention of Herpes Labialis Introduction
11.3.4 Teva Revenue in Treatment and Prevention of Herpes Labialis Business (2016-2021)
11.3.5 Teva Recent Development
11.4 Mylan
11.4.1 Mylan Company Details
11.4.2 Mylan Business Overview
11.4.3 Mylan Treatment and Prevention of Herpes Labialis Introduction
11.4.4 Mylan Revenue in Treatment and Prevention of Herpes Labialis Business (2016-2021)
11.4.5 Mylan Recent Development
11.5 Cadila
11.5.1 Cadila Company Details
11.5.2 Cadila Business Overview
11.5.3 Cadila Treatment and Prevention of Herpes Labialis Introduction
11.5.4 Cadila Revenue in Treatment and Prevention of Herpes Labialis Business (2016-2021)
11.5.5 Cadila Recent Development
11.6 Apotex
11.6.1 Apotex Company Details
11.6.2 Apotex Business Overview
11.6.3 Apotex Treatment and Prevention of Herpes Labialis Introduction
11.6.4 Apotex Revenue in Treatment and Prevention of Herpes Labialis Business (2016-2021)
11.6.5 Apotex Recent Development
11.7 Daewoong Pharmaceutical
11.7.1 Daewoong Pharmaceutical Company Details
11.7.2 Daewoong Pharmaceutical Business Overview
11.7.3 Daewoong Pharmaceutical Treatment and Prevention of Herpes Labialis Introduction
11.7.4 Daewoong Pharmaceutical Revenue in Treatment and Prevention of Herpes Labialis Business (2016-2021)
11.7.5 Daewoong Pharmaceutical Recent Development
11.8 Livzon
11.8.1 Livzon Company Details
11.8.2 Livzon Business Overview
11.8.3 Livzon Treatment and Prevention of Herpes Labialis Introduction
11.8.4 Livzon Revenue in Treatment and Prevention of Herpes Labialis Business (2016-2021)
11.8.5 Livzon Recent Development
11.9 Luoxin
11.9.1 Luoxin Company Details
11.9.2 Luoxin Business Overview
11.9.3 Luoxin Treatment and Prevention of Herpes Labialis Introduction
11.9.4 Luoxin Revenue in Treatment and Prevention of Herpes Labialis Business (2016-2021)
11.9.5 Luoxin Recent Development
11.10 Med shine
11.10.1 Med shine Company Details
11.10.2 Med shine Business Overview
11.10.3 Med shine Treatment and Prevention of Herpes Labialis Introduction
11.10.4 Med shine Revenue in Treatment and Prevention of Herpes Labialis Business (2016-2021)
11.10.5 Med shine Recent Development
11.11 Bayer(Campho Phenique)
11.11.1 Bayer(Campho Phenique) Company Details
11.11.2 Bayer(Campho Phenique) Business Overview
11.11.3 Bayer(Campho Phenique) Treatment and Prevention of Herpes Labialis Introduction
11.11.4 Bayer(Campho Phenique) Revenue in Treatment and Prevention of Herpes Labialis Business (2016-2021)
11.11.5 Bayer(Campho Phenique) Recent Development
11.12 Blistex
11.12.1 Blistex Company Details
11.12.2 Blistex Business Overview
11.12.3 Blistex Treatment and Prevention of Herpes Labialis Introduction
11.12.4 Blistex Revenue in Treatment and Prevention of Herpes Labialis Business (2016-2021)
11.12.5 Blistex Recent Development
11.13 Kelun Group
11.13.1 Kelun Group Company Details
11.13.2 Kelun Group Business Overview
11.13.3 Kelun Group Treatment and Prevention of Herpes Labialis Introduction
11.13.4 Kelun Group Revenue in Treatment and Prevention of Herpes Labialis Business (2016-2021)
11.13.5 Kelun Group Recent Development
11.14 Hikma
11.14.1 Hikma Company Details
11.14.2 Hikma Business Overview
11.14.3 Hikma Treatment and Prevention of Herpes Labialis Introduction
11.14.4 Hikma Revenue in Treatment and Prevention of Herpes Labialis Business (2016-2021)
11.14.5 Hikma Recent Development
11.15 Haiwang
11.15.1 Haiwang Company Details
11.15.2 Haiwang Business Overview
11.15.3 Haiwang Treatment and Prevention of Herpes Labialis Introduction
11.15.4 Haiwang Revenue in Treatment and Prevention of Herpes Labialis Business (2016-2021)
11.15.5 Haiwang Recent Development
11.16 Carmex
11.16.1 Carmex Company Details
11.16.2 Carmex Business Overview
11.16.3 Carmex Treatment and Prevention of Herpes Labialis Introduction
11.16.4 Carmex Revenue in Treatment and Prevention of Herpes Labialis Business (2016-2021)
11.16.5 Carmex Recent Development
11.17 Cipher
11.17.1 Cipher Company Details
11.17.2 Cipher Business Overview
11.17.3 Cipher Treatment and Prevention of Herpes Labialis Introduction
11.17.4 Cipher Revenue in Treatment and Prevention of Herpes Labialis Business (2016-2021)
11.17.5 Cipher Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Treatment and Prevention of Herpes Labialis Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Valacyclovir
Table 3. Key Players of Aciclovir
Table 4. Key Players of Famciclovir
Table 5. Key Players of Docosanol
Table 6. Key Players of Other
Table 7. Global Treatment and Prevention of Herpes Labialis Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Treatment and Prevention of Herpes Labialis Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Treatment and Prevention of Herpes Labialis Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Treatment and Prevention of Herpes Labialis Market Share by Regions (2016-2021)
Table 11. Global Treatment and Prevention of Herpes Labialis Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Treatment and Prevention of Herpes Labialis Market Share by Regions (2022-2027)
Table 13. Treatment and Prevention of Herpes Labialis Market Trends
Table 14. Treatment and Prevention of Herpes Labialis Market Drivers
Table 15. Treatment and Prevention of Herpes Labialis Market Challenges
Table 16. Treatment and Prevention of Herpes Labialis Market Restraints
Table 17. Global Treatment and Prevention of Herpes Labialis Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Treatment and Prevention of Herpes Labialis Market Share by Players (2016-2021)
Table 19. Global Top Treatment and Prevention of Herpes Labialis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Treatment and Prevention of Herpes Labialis as of 2020)
Table 20. Ranking of Global Top Treatment and Prevention of Herpes Labialis Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Treatment and Prevention of Herpes Labialis Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Treatment and Prevention of Herpes Labialis Product Solution and Service
Table 24. Date of Enter into Treatment and Prevention of Herpes Labialis Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Treatment and Prevention of Herpes Labialis Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Treatment and Prevention of Herpes Labialis Revenue Market Share by Type (2016-2021)
Table 28. Global Treatment and Prevention of Herpes Labialis Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Treatment and Prevention of Herpes Labialis Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Treatment and Prevention of Herpes Labialis Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Treatment and Prevention of Herpes Labialis Revenue Market Share by Application (2016-2021)
Table 32. Global Treatment and Prevention of Herpes Labialis Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Treatment and Prevention of Herpes Labialis Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Treatment and Prevention of Herpes Labialis Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Treatment and Prevention of Herpes Labialis Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Treatment and Prevention of Herpes Labialis Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Treatment and Prevention of Herpes Labialis Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Treatment and Prevention of Herpes Labialis Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Treatment and Prevention of Herpes Labialis Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Treatment and Prevention of Herpes Labialis Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Treatment and Prevention of Herpes Labialis Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Treatment and Prevention of Herpes Labialis Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Treatment and Prevention of Herpes Labialis Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Treatment and Prevention of Herpes Labialis Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Treatment and Prevention of Herpes Labialis Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Treatment and Prevention of Herpes Labialis Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Treatment and Prevention of Herpes Labialis Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Treatment and Prevention of Herpes Labialis Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Treatment and Prevention of Herpes Labialis Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Treatment and Prevention of Herpes Labialis Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Treatment and Prevention of Herpes Labialis Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Treatment and Prevention of Herpes Labialis Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Treatment and Prevention of Herpes Labialis Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Treatment and Prevention of Herpes Labialis Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Treatment and Prevention of Herpes Labialis Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Treatment and Prevention of Herpes Labialis Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Treatment and Prevention of Herpes Labialis Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size by Country (2022-2027) & (US$ Million)
Table 64. GSK Company Details
Table 65. GSK Business Overview
Table 66. GSK Treatment and Prevention of Herpes Labialis Product
Table 67. GSK Revenue in Treatment and Prevention of Herpes Labialis Business (2016-2021) & (US$ Million)
Table 68. GSK Recent Development
Table 69. Novartis Company Details
Table 70. Novartis Business Overview
Table 71. Novartis Treatment and Prevention of Herpes Labialis Product
Table 72. Novartis Revenue in Treatment and Prevention of Herpes Labialis Business (2016-2021) & (US$ Million)
Table 73. Novartis Recent Development
Table 74. Teva Company Details
Table 75. Teva Business Overview
Table 76. Teva Treatment and Prevention of Herpes Labialis Product
Table 77. Teva Revenue in Treatment and Prevention of Herpes Labialis Business (2016-2021) & (US$ Million)
Table 78. Teva Recent Development
Table 79. Mylan Company Details
Table 80. Mylan Business Overview
Table 81. Mylan Treatment and Prevention of Herpes Labialis Product
Table 82. Mylan Revenue in Treatment and Prevention of Herpes Labialis Business (2016-2021) & (US$ Million)
Table 83. Mylan Recent Development
Table 84. Cadila Company Details
Table 85. Cadila Business Overview
Table 86. Cadila Treatment and Prevention of Herpes Labialis Product
Table 87. Cadila Revenue in Treatment and Prevention of Herpes Labialis Business (2016-2021) & (US$ Million)
Table 88. Cadila Recent Development
Table 89. Apotex Company Details
Table 90. Apotex Business Overview
Table 91. Apotex Treatment and Prevention of Herpes Labialis Product
Table 92. Apotex Revenue in Treatment and Prevention of Herpes Labialis Business (2016-2021) & (US$ Million)
Table 93. Apotex Recent Development
Table 94. Daewoong Pharmaceutical Company Details
Table 95. Daewoong Pharmaceutical Business Overview
Table 96. Daewoong Pharmaceutical Treatment and Prevention of Herpes Labialis Product
Table 97. Daewoong Pharmaceutical Revenue in Treatment and Prevention of Herpes Labialis Business (2016-2021) & (US$ Million)
Table 98. Daewoong Pharmaceutical Recent Development
Table 99. Livzon Company Details
Table 100. Livzon Business Overview
Table 101. Livzon Revenue in Treatment and Prevention of Herpes Labialis Business (2016-2021) & (US$ Million)
Table 102. Livzon Recent Development
Table 103. Luoxin Company Details
Table 104. Luoxin Business Overview
Table 105. Luoxin Treatment and Prevention of Herpes Labialis Product
Table 106. Luoxin Revenue in Treatment and Prevention of Herpes Labialis Business (2016-2021) & (US$ Million)
Table 107. Luoxin Recent Development
Table 108. Med shine Company Details
Table 109. Med shine Business Overview
Table 110. Med shine Treatment and Prevention of Herpes Labialis Product
Table 111. Med shine Revenue in Treatment and Prevention of Herpes Labialis Business (2016-2021) & (US$ Million)
Table 112. Med shine Recent Development
Table 113. Bayer(Campho Phenique) Company Details
Table 114. Bayer(Campho Phenique) Business Overview
Table 115. Bayer(Campho Phenique) Treatment and Prevention of Herpes Labialis Product
Table 116. Bayer(Campho Phenique) Revenue in Treatment and Prevention of Herpes Labialis Business (2016-2021) & (US$ Million)
Table 117. Bayer(Campho Phenique) Recent Development
Table 118. Blistex Company Details
Table 119. Blistex Business Overview
Table 120. Blistex Treatment and Prevention of Herpes Labialis Product
Table 121. Blistex Revenue in Treatment and Prevention of Herpes Labialis Business (2016-2021) & (US$ Million)
Table 122. Blistex Recent Development
Table 123. Kelun Group Company Details
Table 124. Kelun Group Business Overview
Table 125. Kelun Group Treatment and Prevention of Herpes Labialis Product
Table 126. Kelun Group Revenue in Treatment and Prevention of Herpes Labialis Business (2016-2021) & (US$ Million)
Table 127. Kelun Group Recent Development
Table 128. Hikma Company Details
Table 129. Hikma Business Overview
Table 130. Hikma Treatment and Prevention of Herpes Labialis Product
Table 131. Hikma Revenue in Treatment and Prevention of Herpes Labialis Business (2016-2021) & (US$ Million)
Table 132. Hikma Recent Development
Table 133. Haiwang Company Details
Table 134. Haiwang Business Overview
Table 135. Haiwang Treatment and Prevention of Herpes Labialis Product
Table 136. Haiwang Revenue in Treatment and Prevention of Herpes Labialis Business (2016-2021) & (US$ Million)
Table 137. Haiwang Recent Development
Table 138. Carmex Company Details
Table 139. Carmex Business Overview
Table 140. Carmex Treatment and Prevention of Herpes Labialis Product
Table 141. Carmex Revenue in Treatment and Prevention of Herpes Labialis Business (2016-2021) & (US$ Million)
Table 142. Carmex Recent Development
Table 143. Cipher Company Details
Table 144. Cipher Business Overview
Table 145. Cipher Treatment and Prevention of Herpes Labialis Product
Table 146. Cipher Revenue in Treatment and Prevention of Herpes Labialis Business (2016-2021) & (US$ Million)
Table 147. Cipher Recent Development
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Treatment and Prevention of Herpes Labialis Market Share by Type: 2020 VS 2027
Figure 2. Valacyclovir Features
Figure 3. Aciclovir Features
Figure 4. Famciclovir Features
Figure 5. Docosanol Features
Figure 6. Other Features
Figure 7. Global Treatment and Prevention of Herpes Labialis Market Share by Application: 2020 VS 2027
Figure 8. External Use Case Studies
Figure 9. Oral Case Studies
Figure 10. Injection Case Studies
Figure 11. Treatment and Prevention of Herpes Labialis Report Years Considered
Figure 12. Global Treatment and Prevention of Herpes Labialis Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Treatment and Prevention of Herpes Labialis Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Treatment and Prevention of Herpes Labialis Market Share by Regions: 2020 VS 2027
Figure 15. Global Treatment and Prevention of Herpes Labialis Market Share by Regions (2022-2027)
Figure 16. Global Treatment and Prevention of Herpes Labialis Market Share by Players in 2020
Figure 17. Global Top Treatment and Prevention of Herpes Labialis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Treatment and Prevention of Herpes Labialis as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Treatment and Prevention of Herpes Labialis Revenue in 2020
Figure 19. Global Treatment and Prevention of Herpes Labialis Revenue Market Share by Type (2016-2021)
Figure 20. Global Treatment and Prevention of Herpes Labialis Revenue Market Share by Type (2022-2027)
Figure 21. North America Treatment and Prevention of Herpes Labialis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Treatment and Prevention of Herpes Labialis Market Share by Type (2016-2027)
Figure 23. North America Treatment and Prevention of Herpes Labialis Market Share by Application (2016-2027)
Figure 24. North America Treatment and Prevention of Herpes Labialis Market Share by Country (2016-2027)
Figure 25. United States Treatment and Prevention of Herpes Labialis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Treatment and Prevention of Herpes Labialis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Treatment and Prevention of Herpes Labialis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Treatment and Prevention of Herpes Labialis Market Share by Type (2016-2027)
Figure 29. Europe Treatment and Prevention of Herpes Labialis Market Share by Application (2016-2027)
Figure 30. Europe Treatment and Prevention of Herpes Labialis Market Share by Country (2016-2027)
Figure 31. Germany Treatment and Prevention of Herpes Labialis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Treatment and Prevention of Herpes Labialis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Treatment and Prevention of Herpes Labialis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Treatment and Prevention of Herpes Labialis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Treatment and Prevention of Herpes Labialis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Treatment and Prevention of Herpes Labialis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Treatment and Prevention of Herpes Labialis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Treatment and Prevention of Herpes Labialis Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Treatment and Prevention of Herpes Labialis Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Treatment and Prevention of Herpes Labialis Market Share by Region (2016-2027)
Figure 41. China Treatment and Prevention of Herpes Labialis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Treatment and Prevention of Herpes Labialis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Treatment and Prevention of Herpes Labialis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Treatment and Prevention of Herpes Labialis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Treatment and Prevention of Herpes Labialis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Treatment and Prevention of Herpes Labialis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Treatment and Prevention of Herpes Labialis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Treatment and Prevention of Herpes Labialis Market Share by Type (2016-2027)
Figure 49. Latin America Treatment and Prevention of Herpes Labialis Market Share by Application (2016-2027)
Figure 50. Latin America Treatment and Prevention of Herpes Labialis Market Share by Country (2016-2027)
Figure 51. Mexico Treatment and Prevention of Herpes Labialis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Treatment and Prevention of Herpes Labialis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Treatment and Prevention of Herpes Labialis Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Treatment and Prevention of Herpes Labialis Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Treatment and Prevention of Herpes Labialis Market Share by Country (2016-2027)
Figure 57. Turkey Treatment and Prevention of Herpes Labialis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Treatment and Prevention of Herpes Labialis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Treatment and Prevention of Herpes Labialis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. GSK Revenue Growth Rate in Treatment and Prevention of Herpes Labialis Business (2016-2021)
Figure 61. Novartis Revenue Growth Rate in Treatment and Prevention of Herpes Labialis Business (2016-2021)
Figure 62. Teva Revenue Growth Rate in Treatment and Prevention of Herpes Labialis Business (2016-2021)
Figure 63. Mylan Revenue Growth Rate in Treatment and Prevention of Herpes Labialis Business (2016-2021)
Figure 64. Cadila Revenue Growth Rate in Treatment and Prevention of Herpes Labialis Business (2016-2021)
Figure 65. Apotex Revenue Growth Rate in Treatment and Prevention of Herpes Labialis Business (2016-2021)
Figure 66. Daewoong Pharmaceutical Revenue Growth Rate in Treatment and Prevention of Herpes Labialis Business (2016-2021)
Figure 67. Livzon Revenue Growth Rate in Treatment and Prevention of Herpes Labialis Business (2016-2021)
Figure 68. Luoxin Revenue Growth Rate in Treatment and Prevention of Herpes Labialis Business (2016-2021)
Figure 69. Med shine Revenue Growth Rate in Treatment and Prevention of Herpes Labialis Business (2016-2021)
Figure 70. Bayer(Campho Phenique) Revenue Growth Rate in Treatment and Prevention of Herpes Labialis Business (2016-2021)
Figure 71. Blistex Revenue Growth Rate in Treatment and Prevention of Herpes Labialis Business (2016-2021)
Figure 72. Kelun Group Revenue Growth Rate in Treatment and Prevention of Herpes Labialis Business (2016-2021)
Figure 73. Hikma Revenue Growth Rate in Treatment and Prevention of Herpes Labialis Business (2016-2021)
Figure 74. Haiwang Revenue Growth Rate in Treatment and Prevention of Herpes Labialis Business (2016-2021)
Figure 75. Carmex Revenue Growth Rate in Treatment and Prevention of Herpes Labialis Business (2016-2021)
Figure 76. Cipher Revenue Growth Rate in Treatment and Prevention of Herpes Labialis Business (2016-2021)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
世界の生殖器ヘルペス治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Genital Herpes Treatment Market The global Genital Herpes Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the …- 世界の生殖器ヘルペス治療薬市場規模・現状・予測（2021年-2027年） Genital herpes is a sexually transmitted disease (STD). This STD causes herpetic sores, which are painful blisters (fluid-filled bumps) that can break open and ooze fluid. About 16 percentTrusted Source of people between the ages of 14 and 49 have this STD. Market Analysis and Insights: Global Genit…
- 世界の帯状疱疹治療市場規模・現状・予測（2021年-2027年） Herpes Zoster, also known as zoster or shingles, is a viral disease characterized by a painful skin rash with blisters in a localized area. Typically the rash occurs in a single, wide stripe either on the left or right side of the body or face. Two to four days before the rash occurs there may be ti…
- 世界の胃がん検査・治療・予防市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Gastric Cancer Testing, Treatment and Prevention Market The global Gastric Cancer Testing, Treatment and Prevention market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard ac…
- 世界の早産予防＆治療市場規模・現状・予測（2021年-2027年） Preterm birth is among the prevalent public health concerns all over the world and has become the primary cause of mortality in children aging below 5 years. To curb the alarming situation, governments including, the Food and Drug Administration (FDA), are showing immediacy in approving drugs for pr…